A Safety Study in Patients With Chronic Lymphocytic Leukemia

Clinical trial NCT00283101 · COMPLETED

Trial details

NCT number: NCT00283101
Sponsor: Seagen Inc.
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Leukemia, Lymphocytic, Chronic

Start date: 2005-07-01
Primary completion: 2006-10-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.